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A Mycobacterium avium subsp.
paratuberculosis relA deletion mutant
and a 35 kDa major membrane protein elicit
development of cytotoxic T lymphocytes
with ability to kill intracellular bacteria
Gaber S. Abdellrazeq1,2, Mahmoud M. Elnaggar1,2, John P. Bannantine3, Kun T. Park4, Cleverson D. Souza5,
Brian Backer6, Victoria Hulubei1, Lindsay M. Fry7, Samy A. Khaliel2, Helmy A. Torky2, David A. Schneider1,7
and William C. Davis1*

Abstract
Efforts to develop live attenuated vaccines against Mycobacterium avium subspecies paratuberculosis (Map), using
indirect methods to screen Map deletion mutants for potential efficacy, have not been successful. A reduction in
the capacity to survive in macrophages has not predicted the ability of mutants to survive in vivo. Previous studies
for screening of three deletion mutants in cattle and goats revealed one mutant, with a deletion in relA (ΔMap/relA),
could not establish a persistent infection. Further studies, using antigen presenting cells (APC), blood dendritic cells
and monocyte derived DC, pulsed with ΔMap/relA or a 35 kDa Map membrane protein (MMP) revealed a component
of the response to ΔMap/relA was directed towards MMP. As reported herein, we developed a bacterium viability
assay and cell culture assays for analysis and evaluation of cytotoxic T cells generated against ΔMap/relA or MMP.
Analysis of the effector activity of responding cells revealed the reason ΔMap/relA could not establish a persistent
infection was that vaccination elicited development of cytotoxic CD8 T cells (CTL) with the capacity to kill intracellular
bacteria. We demonstrated the same CTL response could be elicited with two rounds of antigenic stimulation of APC
pulsed with ΔMap/relA or MMP ex vivo. Cytotoxicity was mediated through the perforin granzyme B pathway. Finally,
cognate recognition of peptides presented in context of MHC I and II molecules to CD4 and CD8 T cells is required for
development of CTL.
Introduction
Mycobacterium avium subspecies paratuberculosis
(Map) is a pathogen with a broad host range. It is the
causative agent of Johne’s disease (JD) in cattle, a major
disease problem in the US and other countries [1].
Cumulative studies now show humans are susceptible to
infection with Map. Studies have revealed some infected
subjects develop clinical disease manifestations varying
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from an ileitis in humans referred to as Crohn’s disease,
to other diseases associated with autoimmunity [2–5].
To reduce exposure of the public to Map, there is a need
to find ways to clear dairy herds of Map. This has proven
difficult, however, because efforts to date have not yielded
a vaccine that elicits a protective immune response. This
is attributable in part to the lack of methods to accurately
predict the efficacy of candidate vaccines before testing
in the field.
As illustrated by results from a standardized multiinstitutional vaccine study, the use of macrophages and
mice as indirect approaches to screen a set of candidate
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Map mutant vaccines for efficacy were not successful [6,
7]. The conclusion drawn from the study suggested more
direct methods are needed to fully evaluate the immune
response to candidate vaccines in the natural host [7,
8]. Many of the mutants submitted for evaluation in the
study were excluded from a vaccine trial in the natural
host because they did not exhibit efficacy in macrophage
and mouse model systems [8]. This was the fate of the
three mutants our group submitted for evaluation in the
study. Studies in cattle and goats, however, had shown
deletion of one gene, relA, interfered with the capacity
of Map to establish a persistent infection, indicating the
mutant was a good candidate for further evaluation [9].
An immune response to the mutant cleared infection
and limited the capacity of wild type Map to establish an
infection [10].
In light of the problems of using indirect methods of
assessing the potential efficacy of candidate vaccines,
we focused on development of methods to examine the
immune response to candidate vaccines in the natural
host. We developed an ex vivo platform to study the functional activity of T lymphocytes proliferating in response
to live-attenuated and peptide-based candidate vaccines.
The first studies conducted with steers vaccinated with
ΔMap/relA demonstrated a CD4 and CD8 T cell recall
response could be elicited ex vivo from peripheral blood
mononuclear cells (PBMC) stimulated with ΔMap/relA
[9, 11]. Development of a monoclonal antibody (mAb)
to CD209, uniquely expressed on blood APC, dendritic
cells (bDC), monocyte derived dendritic cells (MoDC),
and monocyte derived macrophages (MoMΦ), allowed
us to extend the studies and characterize the response in
greater detail using APC pulsed with Ag for Ag presentation to T cells [12]. Analysis revealed the recall response
could be elicited by antigenic peptides presented by
APC pulsed with ΔMap/relA. Presentation of antigens
by APC was blocked by mAbs specific for MHC class I
and II molecules showing the recall response was MHC
restricted [12].
Further studies were conducted to dissect the recall
response and determine which antigens were presented
by the APC. This approach revealed a major component
of the response was directed towards a 35 kDa membrane
protein of Map, termed MMP [13]. The recall response
to MMP was equivalent to the response elicited by
ΔMap/relA [12]. As reported herein, further analysis of
the immune response to ΔMap/relA and MMP required
development of two assays: (1) a bacterium viability assay
that was faster than the colony forming unit (CFU) assay
for assessment of CTL activity against Map and (2) a
method to characterize the functional activity of CD4
and CD8 T cells ex vivo. These newly developed assays
demonstrated that vaccination with ΔMap/relA elicits
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the development of CTL with the ability to kill intracellular bacteria. Further analysis revealed the CTL activity
was directed towards MMP. Follow up studies with MMP,
ex vivo, demonstrated the same CTL response could be
elicited with APC from unvaccinated cattle pulsed with
MMP. Analysis the CTL activity revealed cytotoxicity
was mediated through the perforin granzyme B (GrzB)
pathway.

Materials and methods
Animals

Eight Holstein steers were obtained from the Map free
Washington State University (WSU) dairy herd from
2013 to 2017. In the first phase of the study, two of the
steers were vaccinated with the ΔMap/relA mutant and
maintained as a source of blood to characterize cell
responses elicited by ΔMap/relA and MMP. Two additional age-matched naïve steers were maintained as controls. In the second phase of the study, four additional
unvaccinated naïve steers were used as a source of blood
to conduct the ex vivo studies on the immune response
to ΔMap/relA and MMP. The vaccinated steers were kept
in an open feed lot since initial studies demonstrated the
mutant ΔMap/relA was immune eliminated and did not
present a health risk to other cattle under study [9]. All
the steers were maintained by the college staff. The steers
were in good health during the studies. Midway through
the initial studies, however, one of the vaccinated steers
had to be euthanized because he was unruly and an
injury risk to the staff. All protocols were approved by
the WSU Institutional Animal Care and Use Committee
(ASAFs 3360 and 04883).
Preparation of Map K10, K
 10GFP, ΔMap/relA, and MMP

The ΔMap/relA mutant was constructed in the K-10
and K10GFP strains of Map using site directed allelic
exchange, as previously described [14]. Cultures of Map
K10, K10GFP, and ΔMap/relA were prepared from single
colonies and used to inoculate Middlebrook 7H9 broth
flasks (Difco, BD biosciences, USA) supplemented with
6.7% para-JEM GS (Trek Diagnostic Systems, OH, USA),
2 μg/mL mycobactin J (Allied Monitor, MO, USA), and
0.05% Tween 80 (Sigma-Aldrich Corp.) [9, 14]. The cultures were expanded on a shaking stand at 37 °C. When
the broth cultures reached an OD600 of 0.6–0.8, master
stocks were prepared in 1.5 mL micro-centrifuge screwcap tubes for immediate use in each experiment. To
ensure a single-cell suspension, bacterial stocks were disaggregated by passages through a 26-gauge needle three
times, then the bacterial numbers were estimated based
on the final OD600 values [14].
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The full length MMP is encoded by MAP2121c in the
K-10 genome [15]. It was expressed in ClearColi as a
maltose-binding protein for purification [16].
Bacterium viability assay

The Map viability assay was adapted from a method
developed by Kralik et al. [17] to distinguish and quantify
the concentration of live Map present in food products
and samples from the environment. The method involves
the use of propidium monoazide (PMA), a membrane
impermeant fluorescent compound similar to propidium
iodide. It only enters dead cells and intercalates into DNA
[18]. When it is activated by light, it binds covalently to
DNA and blocks binding of probes used to detect Map
genes. The concentration of live Map in a mixture of live
and dead bacteria is determined from a standard curve
generated with known concentrations of pure DNA from
live Map. The number of live bacteria present in a sample preparation is determined by using quantitative PCR
(qRT-PCR) with a probe specific for a single copy gene,
F57, specific for Map [17]. Two types of controls were
used to adapt the PMA method for measuring Map killing. The first set of controls was used to demonstrate the
concentration of live Map in a defined mixture of live and
dead bacteria, which was determined from a standard
curve generated with DNA from a known number of live
Map. The controls were prepared from pure DNA from
live Map for use as reference standards for extrapolating the extent of killing mediated by Ag-specific CTL. In
the first set of controls, tubes were prepared to contain
2 × 107 Map/ tube. One set was heat-killed by incubating Map at 90 °C for 15 min. Tubes were then prepared
to contain 100% live, 50% live/50% killed and 100% killed
Map suspended in 400 μL of H
 2O in 1.5 mL translucent
Eppendorf tubes and stored at −20 °C until processed.
The second set of controls was used to quantitate the
number of live Map present in Map-infected MoMΦ
(generation of MoMΦ described below). This set of controls was essential for determining the extent of killing by
CTLs since it covered the dynamic range for detection of
live vs dead Map obtained from infected MoMΦ before
and after incubation with CTL. Aliquots of Map mixed in
four ratios, 100% live, 75% live/25% killed, 25% live/75%
killed, and 100% killed, were prepared and added to the
cultures of MoMΦ at a MOI of 10 respectively and incubated for 3 h. The cultures were then washed to remove
free bacteria. In this set of controls, cells were lysed following infection and incubation with Map by adding
2 mL of 0.01% saponin in H2O and incubating at 37 °C
for 15 min. The cell lysates were centrifuged for 30 min
at 4500 rpm to pellet the bacteria. The supernatants were
discarded and the pellets re-suspended in 1 mL H2O
and transferred into micro-centrifuge tubes. The second
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centrifugation step was performed to harvest the washed
bacteria at 14 000 rpm for 10 min. The supernatants were
discarded, and the pellets re-suspended in 400 μL of H2O
in 1.5 mL translucent Eppendorf tubes and stored at
−20 °C until used.
Treatment with PMA to block binding of the F57 probe

The basic procedure for PMA treatment was carried
out according the manufacturer’s instructions. 1 µL of
20 mM PMA working stock solution was added to 400 µL
of the previously prepared preparations of cell controls to
reach a final dye concentration of 50 µM. The translucent
PMA-treated tubes were incubated at room temperature
for 5 min in the dark on a rocker followed by brief spinning. To avoid overheating during exposure to the halogen light, a plastic tray was prepared with a frozen ice
pack wrapped in aluminum foil. The tubes were placed in
a diagonal slant position on top of the ice pack. The tray
was then set on a rocking platform to ensure continuous
mixing during light exposure. Light exposure was performed for 5 min using a halogen lamp with a 650 W bulb
placed at a distance of ~20 cm from the tubes. Cells were
subsequently harvested by centrifugation at 10 000 × g
for 5 min. The supernatants were discarded and the cell
pellets from the two sets of controls processed for isolation of DNA [19].
DNA extraction

DNA was extracted using the protocol for Gram-positive
bacteria using DNeasy® Blood and Tissue kit (Qiagen,
USA) following enzymatic lysis to facilitate breakdown
of the Map cell wall as described by Park et al. [19]. In
all cases, DNA extraction was performed in duplicate.
The DNA was eluted in 100 μL of the designated elution buffer in the kits. DNA yield was measured by a
NanoDrop® ND-1000 Spectrophotometer (Thermo
Fisher Scientific Inc., Waltham, USA) using A260/280 ratio
with 1 μL of sample.
Quantitative real‑time PCR

We used the TaqMan RT-PCR method, targeting the single copy F57 gene specific for Map (F57 qPCR) to quantify the relative concentration of live Map in all samples
[20]. The StepOnePlus Real-Time PCR System machine
(Applied Biosystems, CA, USA) was used to collect
the data. Each DNA sample was diluted to 1 ng/μL and
run in duplicate. The total reaction volume was 25 μL
including 5 μL of the DNA sample. The qPCR conditions and sequences for primer and probe were the same
as previously described [19]. The reactions were run for
40 cycles. Genomic DNA (gDNA) prepared from a pure
culture of Map, was used to generate the standard curve
using the F57 probe. Eight dilutions of DNA were used,
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starting with 4 × 107 copies diluted down to 4 copies. The
mass of one copy of Map gDNA was calculated using the
following equation:

 
m = (n) × 1.096 × 10−21 g bp ,
where n is the genomic size and m is the mass of the
genome [19]. The qPCR results were analyzed using StepOne Software v2.1 (Applied Biosystems). A reduction in
signal correlates with a reduction in the live Map present
in a preparation of Map containing live and dead Map.
The frequencies of viable Map present in the samples
were determined based on the means of the threshold
(CT) values as described by Kralik et al. [17]. CT values
are inverse to the amount of amplified target gene in the
tested sample (lower C
 T values indicate a higher concentration of the targeted gene and vice-versa).
Ex vivo assays to characterize the functional activity of CD4
and CD8 T cells

The flow diagram in Figure 1 illustrates the ex vivo protocols used to conduct the studies with cells obtained from
the vaccinated and unvaccinated steers.
Generation of MoDC and CTL from PBMC
from the vaccinated and unvaccinated control steers

As illustrated in Figure 1, the first blood draw from the
vaccinated and unvaccinated control steers was used to
generate MoDC for antigen (Ag) presentation to monocyte depleted PBMC (mdPBMC). Magnetic microbeads
coated with a cross-reactive anti-human CD14 mAb
were used to isolate monocytes per the manufacturer’s
instructions (Miltenyi Biotec) [21]. The average purity
of isolated CD14+ cells was greater than 98%, as determined by FC analysis using an anti-bovine CD14 mAb,
CAM36A [11, 22]. Monocytes (2 × 106) were added to
wells of six well culture plates and cultured in 3 mL of
complete culture medium (cRPMI) [RPMI-1640 medium
with GlutaMAX™ (Life Technologies, CA, USA) supplemented with 10% calf bovine serum (CBS), 1 mM
β-mercaptoethanol, 100 units/mL of penicillin G, and
100 μg/mL of streptomycin sulfate] in the presence of a
DC growth cocktail containing bovine GM-CSF and IL-4
(Kingfisher Biotech, MN, USA). On the 3rd day, 1.4 mL of
the medium was replaced with 1.8 mL of fresh medium
containing the cocktail. The cultures were incubated
for an additional 3 days to obtain MoDC. ΔMap/relA
(5 × 106 Map/well) or MMP (5 μg/mL) were added to
the cultures of MoDC and incubated for 3 h at 37 °C, 5%
CO2. The adherent MoDC were then carefully washed 3
times with warm RPMI (without antibiotics) to remove
free bacteria or MMP.

Figure 1 Protocol for testing activity of CD4, CD8 T cells
stimulated with Ag-pulsed bDC, MoDC. See “Materials and
methods” for detail.

Following preparation of fresh PBMC from the second blood draw of the vaccinated and control steers, one
portion was used to prepare monocyte depleted PBMC
(mdPBMC), as described, using magnetic beads coated
with anti-CD14 to remove monocytes. The mdPBMC,
were added to their respective autologous MoDC
pulsed with ΔMap/relA or MMP (2 × 106/mL in 5 mL of
cRPMI). Following 6 days of culture, the cells were collected and used in FC and the Map killing assay. The second portion of fresh PBMC was used to generate MoMΦ
as described below for use in the ex vivo studies.
Generation of MoDC and CTL from PBMC
from the unvaccinated steers

Two rounds of antigenic stimulation were used to generate CTL from mdPBMC from the unvaccinated steers.
The same general protocol was used as illustrated in Figure 1. The main difference is that the first blood draw
from the unvaccinated steers was used for (1) the first
round of stimulation of mdPBMC with ΔMap/relA and
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MMP, processed and presented by bDC (present in the
mdPBMC) and (2) to generate MoDC for use in the second round of antigen (Ag) presentation to mdPBMC by
MoDC pulsed with ΔMap/relA or MMP. The second
blood draw was used to generate MoMΦ for use as target
cells. The rest of the protocol was identical to the protocol described in Figure 1.
Generation of MoMΦ for use as target cells

At the times indicated in the protocol, fresh PBMC were
re-suspended in cRPMI, placed in 150 mm tissue culture
plates and incubated overnight. The majority of the nonadherent cells were then removed the following day. The
adherent cells were cultured in fresh medium for 4 days
then brought into suspension by incubating them on ice
in the presence of EDTA in PBS [4 mL EDTA (250 mM
stock in H
 2O), 5 mL CBS, 91 mL PBS]. The cells were resuspended in cRPMI, counted, and then used to prepare
MoMΦ for scanning confocal microscopy or use in the
viability assay.
Infection of MoMΦ with Map K10GFP for scanning confocal
microscopy

A two chamber culture slide was used to prepare cultures of MoMΦ infected with Map K10GFP to determine whether a 3 h incubation time is sufficient for
preparing infected MoMΦ for use in the intracellular
killing assay. MoMΦ were added to the two chambers
(~2 × 104 MoMΦ/well) of the culture slide. After 2 days of
additional culture, the MoMΦs were infected with K10GFP
at a MOI of 10:1 (2 × 105 K10GFP to ~2 × 104 MoMΦ) in
antibiotic free cRPMI. The slide was incubated at 37 °C,
5% CO2 for 3 h. Immediately following incubation, the
medium containing free bacteria was washed away with
warm cRPMI. The cells were then treated with a saponinbased permeabilization and wash reagent (BD Pharmingen) for 30 min at room temperature, then washed once
with 1 mL of PBS. The cells were counter stained for
5 min with 500 µL of diluted (1:3000) propidium iodide
stain (1 mg/mL stock solution, Invitrogen). Subsequently,
the cells were rinsed several times in PBS then fixed with
2% formaldehyde in PBS overnight at 4 °C. After fixation
the cells were covered with Vectasheild antifade agent and
imaged on a Leica SP8 scanning confocal microscope,
using the Leica Application Suite X software 1.10.12420.
Infection of MoMΦ for use in the viability assay

MoMΦ were distributed into six well culture plates
(2 × 106 cells/well) and cultured for an additional 2 days
and then used as target cells.
MoMΦ were infected with Map at a multiplicity of
infection (MOI) of 10:1 (2 × 107 Map to ~2 × 106 MoMΦ/
well) in antibiotic free cRPMI. The culture plates were
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centrifuged at 700 × g for 5 min, then incubated at 37 °C,
5% CO2 for 3 h. Extracellular bacteria were removed by
washing 5 times with warm RPMI with no antibiotics.
A vacuum source, equipped with a side-arm flask, rubber tubing and a pipette tip, was used for liquid removal
in culture wells to avoid detaching the adherent MoMΦ.
Two wells from each of the respective sets of 6 wells,
containing Map infected MoMΦ, were used as controls,
without addition of primed or unprimed preparations of
mdPBMC.
Incubation of mdPBMC from the vaccinated
and the control steers with MoMΦ alone or infected
with Map

mdPBMC prepared from the vaccinated and control
steers as outlined in Figure 1, were added to the cultures of MoMΦ alone or MoMΦ infected with Map
(2 × 106 cells/well). After incubation for 6 h, the nonadherent cells were washed away with warm RPMI. The
remaining MoMΦ were collected and processed for the
Map viability assay.
Incubation of mdPBMC from unvaccinated steers
with MoMΦs, alone or infected with Map

mdPBMC preparations from the unvaccinated steers
prepared according to the protocol, were added to the
preparations of MoMΦ alone or infected with Map
(2 × 106 cells/well) and incubated for 24 h. The nonadherent cells were collected and held separately until
collection of the adherent cells and then recombined for
analysis of Map viability.
Cell processing for the Map viability assay

Cells in one control well of infected MoMΦ were lysed
immediately following infection with Map using 0.01%
saponin in H
 2O as described. The pellets were re-suspended in 400 μL of H
 2O in 1.5 mL translucent Eppendorf tubes and stored at −20 °C for later analysis. The
other control well was incubated for 6 or 24 h concurrent
with infected MoMΦ cultures overlaid with Ag-primed
or unprimed preparations of mdPBMC. At the end of
respective incubation times, all cultures were lysed as
described. All lysed cells were treated with PMA and
subjected to DNA extraction followed by qPCR as previously described in the viability assay to determine the
extent of intracellular killing.
Intracellular labeling for perforin and GrzB

mdPBMC, prepared according the protocol (Figure 1)
and co-cultured with Map-infected and non-infected
MoMΦ for 24 h, were used to determine the frequency
of CD4 and CD8 T cells positive for perforin and GnzB
following incubation. In these sets of cells, Brefeldin A
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(BFA; 1 μg/mL, BD Biosciences) was added during the
last 12 h of incubation to block secretion of proteins. The
intracellular staining was carried out as described [23]
with minor modification. In brief, the non-adherent cells
were harvested and labeled for surface staining. Then,
cells were fixed and permeabilized using BD Cytofix/
Cytoperm fixation permeabilization solution kit (BD Bioscience) for 30 min in the dark on ice followed by washing in Perm/Wash buffer. The cells were re-suspended in
Perm/Wash buffer and labeled intracellularly with different combinations of the mAbs shown in Table 1. Data
were collected on a modified FACS Calibur DxP8 Analyzer equipped with a FlowJo operating system (Cytek
Biosciences Inc. Fremont, CA, USA).
Apoptosis

Aliquots of Map infected MoMΦ incubated with Agprimed mdPBMC for 24 h were collected and used
to examine the role of apoptosis in intracellular killing of Map, using a PE Annexin V Apoptosis kit (BD
Pharmingen). [The kit includes Annexin V conjugated
with phycoerythrin (PE) and 7AAD, a fluorescent
membrane impermeant dye that is taken up by dead
cells with a permeant membrane. Annexin V detects
the changes in the membrane during the early stages
of apoptosis. As apoptosis progresses with disruption
in the integrity of the membrane, cells become double
positive, necrotic]. Non-adherent cells comprised of
lymphocytes and MoMΦ, from each culture were collected and held in suspension. The adherent cells from
each cell culture were suspended and added to the corresponding preparation of non-adherent cells. The cells
were pelleted by low speed centrifugation and re-suspended in PBS. Approximately 1 × 106 cells were transferred into 5 mL tubes and washed twice with cold PBS.
Cells were then labeled according to the manufacturer’s
instructions. Two types of controls were included in

this assay (1) uninfected MoMΦ alone and (2) uninfected MoMΦ incubated with MMP-primed mdPBMC.
The cell preparations were analyzed by FC within 1 h
of labeling by gating only on MoMΦ. At least 105 gated
events were collected for each cell preparation.
One set of the cultures used for the apoptosis study,
as described above, was maintained for 3 days after
initiation of co-culture of mdPBMC, to determine
whether necrosis or apoptosis increased over time.
Flow cytometry (FC)

Cells, prepared for FC analysis at the times indicated in
the protocol (Figure 1), were washed one time in PBS/
ACD, centrifuged, then re-suspended in serum-free
RPMI and counted. For cell labeling, cells were distributed in 96 well polystyrene V-shape bottom microplates (106 cells/well). Combinations of mAbs (Table 1),
obtained from the WSU Monoclonal Antibody Center
(WSUMAC), were used for labeling as previously
described [24]. Data were collected on a FACSort
(BD Immunocytometry systems, San Jose, CA, USA)
equipped with Cell Quest software. The gating strategy
used to collect the data is shown in Figure 2.
Statistical analysis

Data were imported into JMP software (version 12.0.1;
SAS Institute Inc., Cary, NC, USA) for statistical analysis and graphical presentation (means and standard
deviations). Two-way ANOVA was used to conduct
statistical analyses and included an interaction term
expect for the analysis of data represented in Figure 6B.
In this instance, the second factor (blood donor) was
instead considered a blocking factor. Post-hoc multiple
comparisons were conducted using Tukey HSD (overall
α = 0.05).

Table 1 MAbs used in the present study
mAb

Isotype

Specificity/source

Fluorochrome

Labeling

ILA11A

IgG2a

CD4 WSUMAC

PE CY5.5

IgG1

CD4 WSUMAC

Alexa Fluor® 647

Indirect

CACT138A
7C2B

IgG2a

CD8 WSUMAC

PE CY5.5

CACT80C

IgG1

CD8 WSUMAC

Alexa Fluor® 647

Indirect

IgG3

CD45R0 WSUMAC

Alexa Fluor® 488; PE

Indirect

ILA116A

IgG1

CD14 WSUMAC

Alexa Fluor® 647

Indirect

CAM36A
209MD26A

IgG2a

CD209 WSUMAC

PE CY5.5

Indirect

Indirect

Indirect

δG9

IgG2b

Perforin Biolegend

PE

Direct

B-D48

IgG1

Perforin Biolegend

PE/CY7

Direct

351927

IgG2a

Granzyme B R&D Systems

PE

Direct
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12%

5%

G3

SSC

48%

39%

SSC

G2

G1

FSC

A

49%

79%

B
G1

G2
FSC

G3
CD4

5%

16%
CD45R0

Figure 2 Flow cytometric gating strategy for analysis CD4, CD8 T cell response to Ag-pulsed bDC/MoDC. Gates were placed to define small
lymphocytes (G1) and large activated lymphocytes (G2) and color coded blue to track activated lymphocytes. A third gate was placed on CD4 cells
in this illustration to isolate activated cells for analysis. Visualization in forward scatter (FSC) vs CD45R0 (memory) shows activated cells that increase
in size appear in G2. A mdPBMC cultured in medium alone for 6 days. B mdPBMC following Ag stimulation and culture for 6 days. Comparison of
cells in A with B show only Ag specific CD4 memory T cells proliferated in response to stimulation with MMP. This population also expressed CD25,
an indication of cells in this gate are activated (not shown). Only the activated proliferating cells in the upper right quadrant were selected for data
analysis. Gated CD8 T cells had equivalent profiles.

Results
Development of a PMA‑based viability assay to quantify
the relative concentration of live Map in a mixed
population of live and dead bacteria

Evidence obtained in previous studies designed to study
the effector T cell response to Mycobacterium tuberculosis (Mtb), used the CFU method to assess survival of bacteria [25, 26]. The lengthy process of CFU determination
did not provide opportunity to examine effector T cell
activity in detail. However, the novel immune cell overlay
model designed to examine the effector T cell response to
BCG infected MoMΦ, provided a method to examine the
effector T cell recall response elicited from APC pulsed
with Ags. To overcome the time required to determine
viability by the CFU method, we adapted the method by
Kralik et al. [17] as an expedient alternative way to distinguish live from dead Map. This approach, which combined a membrane impermeant fluorescent dye (PMA)
with quantitative PCR, eliminated the need to determine
CFU counts for quantifying Map in samples obtained
from food and the environment [17, 27, 28]. Initial studies were conducted to determine whether this PMA
method could be adapted for use in the present study.
As illustrated in Figure 3, we verified it is possible to use
qPCR with a single copy of the Map specific gene, F57, as
a probe to generate a curve with a large dynamic range
(4 × 107 copies of F57 to 4 copies). We then conducted
studies to determine if there was sufficient resolution

to distinguish differences in the relative percent of live
bacteria in preparations of Map containing known proportions of live and dead bacteria, starting with DNA isolated from pure cultures of Map (Figure 3A). There was a
background showing the PMA didn’t block all the DNA
from dead bacteria. However, the mixtures of live and
dead bacteria fit on the curve, with sufficient difference in
CT values between dead and live bacteria to distinguish
and enumerate differences in the percent of live bacteria
present in a mixture of dead and live bacteria. Map DNA
isolated from infected MoMΦ also fit on the standard
curve, but shifted values toward fewer copies of F57 and
higher CT values (Figure 3A).
We next determined if a sufficient number of bacteria were taken up by MoMΦ in a 3 h time frame to be
quantitated using the PMA method. A two well culture
slide was prepared with MoMΦ and infected with Map
K10GFP under the same culture conditions used to set up
infected MoMΦ for the viability assay (see "Materials and
methods"). Confocal microscopy showed efficient bacterial uptake following 3 h of incubation (Figure 3B), even
without a centrifugation step to concentrate the bacteria
to the cell surface of MoMΦ for uptake.
The qPCR assay showed the number of bacteria taken up
was sufficient to consistently determine the relative percent
of live Map present within MoMΦ after 3 h of incubation
(Figure 3D). Importantly, the study showed there was minimal killing of bacteria mediated by MoMΦ during the 6 h
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Figure 3 Killing assay. A Standard curve with 8 dilutions DNA from live Map (red boxes) 4 × 107 to 4 copies. Blue square data points represent
DNA from two sets of controls; the lower set of squares are from Map DNA (2 × 107 Map) prepared from mixtures of 100% live, 50% live/50% dead,
and 100% dead bacteria after PMA treatment. Upper four squares are from DNA isolated from Map after 3 h incubation with MoMΦ. Squares
represent mixtures of Map used to infect MoMΦ, prepared at 2 × 107 Map: 100% live, 75% live 25% dead, 25% live 75% dead and 100% dead
Map. CT values represent average of duplicate preparations of DNA. B Confocal microscopy showing abundance of K 10GFP taken up during 3 h
incubation with MoMΦ. C Killing by effector cells plotted on standard curve from A. CT values of mdPBMC from vaccinated steer with MoDC-pulsed
ΔMap/relA (a: gold box) or MMP (b: green box) and mdPBMC from one control steer stimulated with MoDC pulsed with ΔMap/relA (c: yellow box)
or MMP (d: gray box). D Summary of 6 replications of killing assay comparing killing activity mdPBMC from vaccinated and control steers. Mean
and standard deviation for each treatment effect (n = 6 independent experiments). Two-way ANOVA was significant (F = 88.3205; P < 0.0001) and
included significant interaction effect between treatments and steer-status (F = 46.1411; P < 0.0001). Within unvaccinated steer S1 and vaccinated
steer S3, mean effects of T6-∆Map/relA and T6-MMP were significantly greater than T6-control (each, P < 0.0001; ***S1 not shown). Mean effects
within unvaccinated steer S2 either smaller (T6-∆Map/relA, P = 0.0027; *not shown) or not different (T6-MMP; P = 0.3668) than T6-control. Effect of
T6-∆Map/relA or T6-MMP for vaccinated steer S3 was significantly greater than effect for either unvaccinated steer (each, P < 0.0001).

incubation period with MoMΦ cultured alone or in the
presence of mdPBMC from control steers. (Figure 3D). We
concluded that the dynamic range between live and dead
bacteria isolated from MoMΦ was adequate for studying
the intracellular killing activity of effector CD4 and CD8 T
cells proliferating in response to stimulation with MoDC,
pulsed with ΔMap/relA or MMP.
Analysis of the proliferative response and functional
activity of mdPBMC from the vaccinated and control steers
stimulated by MoDC pulsed with ΔMap/relA or MMP

As reported previously, extensive studies with PBMC
from the vaccinated steers showed a CD4 CD8 T cell

recall response could be elicited ex vivo by stimulation
with ΔMap/relA [11, 12]. The studies demonstrated
an equivalent recall response could be elicited with
mdPBMC using bDC or MoDC pulsed with ΔMap/relA
or MMP. The response was MHC restricted [12]. As
reported here, studies were extended to determine if
the functional activity of the proliferating cells could be
determined using a modification of the intracellular killing assay described by Worku and Hoft [25] and a PMAbased method to distinguish live from dead Map present
in Map-infected MoMΦ [17].
We first examined the effector T cell recall response to
MoDC pulsed with ΔMap/relA and MMP (Figure 4). The
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% Activated CD45R0/CD4 T cells

proliferative responses to ΔMap/relA and MMP were
very similar. We used Map infected-MoMΦ as targets
for the study. The preliminary studies revealed effector
T cells from the vaccinated steer were able to kill intracellular bacteria whereas there was little killing activity observed with cells from the control steers (data not
shown). Further testing with MoDC pulsed with MMP
yielded similar results (data not shown). To complete and
validate the observations, the entire protocol (outlined
in the protocol, Figure 1) was repeated 6 times in parallel with MoDC pulsed with ΔMap/relA in one set and a
second set pulsed with MMP (Figure 3D). As observed
in the preliminary studies to set up the assay, there was
limited intracellular killing by effector cells from the control steer mdPBMCs stimulated once with MoDC pulsed
with ΔMap/relA or MMP (Figures 3C and D). The relative concentration of live bacteria detected in infected
MoMΦ incubated with unstimulated mdPBMC from the
control steers was similar to the concentration present in
infected MoMΦ incubated alone (Figure 3A). In contrast,
few viable Map were present in infected MoMΦ incubated with Ag-primed mdPBMC from the vaccinated
steer. The repeat of the assay 6 times for both ΔMap/relA
and MMP, demonstrated the consistency in results from
test to test as summarized in Figure 3D (P < 0.0001).

***

***

***

***

Figure 4 Two-way ANOVA comparison CD4, CD8 T cell
response unvaccinated and vaccinated steers to Ag-pulsed
MoDC. The factors were steer-status (three levels: S1-unvaccinated,
S2-vaccinated, S3-vaccinated) and treatments (four levels: D0,
Control, ∆Map/relA, MMP). Tukey HSD (overall α = 0.05) was applied
post-hoc to determine the statistical significance of comparisons of
interest. For each T cell type (CD4 and CD8), the mean and standard
deviation for each treatment effect (n = 6 independent experiments)
within each steer-status is shown. The two-way ANOVAs for CD4 and
CD8 T cells were significant (FCD4 = 158.2463, FCD8 = 379.0110; each,
P < 0.0001) and each included a significant interaction effect between
treatments and steer-status (FCD4 = 56.3527, FCD8 = ;165.4418;
each, P < 0.0001). For both CD4 and CD8 T cells, the mean effects
of ∆Map/relA and MMP in vaccinated steer S3 were greater than
in unvaccinated steers S1 and S2 (each, P < 0.0001); significant
differences not detected between unvaccinated steers in the
mean effects of ∆Map/relA (PCD4 = 1.0000, PCD8 = 1.0000) or MMP
(PCD4 = 0.9997, PCD8 = 1.0000).

Analysis of the proliferative and functional activity of naïve
mdPBMC from unvaccinated steers stimulated with bDC
and MoDC pulsed with ΔMap/relA and MMP

The question of why the ΔMap/relA mutant could not
establish a persistent infection was answered [10]. Vaccination elicited a CTL response that cleared the infection
with ΔMap/relA. The ex vivo findings indicated that the
effector activity of CD4 and CD8 T cells from the vaccinated steer, proliferating in response to stimulation with
APC pulsed Map/relA and MMP, was directed towards
MMP (Figures 3 and 4). To extend these findings, we
conducted follow up studies entirely ex vivo. If successful, we postulated this would afford a way to study the
activity of APC at the time of Ag presentation and also
responses of CD4 and CD8 T cells, differentiating in
response to signaling by APC pulsed with Ags. As mentioned in the methods, we modified the stimulation protocol to include two rounds of stimulation of mdPBMC
from the four unvaccinated steers, starting with stimulating mdPBMC with bDC pulsed with ΔMap/relA or MMP
(first round of stimulation) and 6 days later stimulation
with MoDC pulsed with ΔMap/relA or MMP (second
round of stimulation). Comparison of the proliferative
response to ΔMap/relA and MMP showed the responses
were equivalent (data not shown). Based on these observations, further studies were conducted just with MMP.
We repeated the complete protocol with the four steers.
As shown in Figures 5A and B, a proliferative CD4 and
CD8 T cell response to MMP was evident by 6 days.
However, cell proliferation was not sufficient for analysis of CTL activity. There were not enough activated cells
present after one round of stimulation to accurately perform the killing assay. After a second round of stimulation, there was robust proliferation of both CD4 and CD8
T cells, providing enough cells to perform the CTL assay
(Figures 5C, 6A and B).
The essential need for CD4 and CD8 T cell cognate
recognition of MMP peptides presented by APC
for development of CD8 CTL against Map

All the previous studies up to this time were conducted
with mdPBMC because it was unknown whether the
response to Ag peptides, processed and presented by
APC pulsed with ΔMap/relA or MMP, required cognate
recognition of Ag peptides by CD4 and CD8 T cells to
generate CTL activity. Also, it was assumed but not verified that CTL activity was primarily associated with CD8
T cells. To address these unknowns, a series of experiments were conducted with freshly isolated mdPBMC
from the 2 steers. The first experiments focused on determining whether both CD4 and CD8 T cells needed to be
present at the time of Ag presentation to generate CTL
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Figure 5 Comparison response CD4, CD8 T cells from unvaccinated steers stimulated with MMP-pulsed bDC and MoDC. A Representative
flow cytometric profiles showing level of CD4 T cell proliferation following one and two rounds of antigenic stimulation by Ag-pulsed DC. B
Representative flow cytometric profiles showing level of CD8 T cell proliferation following one and two rounds of antigenic stimulation by
Ag-pulsed DC. C Two-way ANOVA with interaction. The factors were type of T cell (two levels: CD4, CD8) and MMP-stimulation (two levels: control,
MMP). Tukey HSD (overall α = 0.05) was applied post-hoc to determine the statistical significance of comparisons of interest. The mean and standard
deviation for each treatment effect for each type of T cell is shown (n = 4 unvaccinated steers). The two-way ANOVA was significant (F = 732.6776;
P < 0.0001). The mean effect of MMP stimulation was significant (Fstimulation = 2188.613, P < 0.0001) but not dependent on T cell type (Finteraction = 1.33;
P = 0.2092). The mean effect of T cell type was small but significant (CD4 effect estimate = 1.55 ± 0.56; FCD = 7.6591, P = 0.0170).

activity. The second set of experiments were focused
on demonstrating whether CTL activity was primarily
associated with CD8 T cells proliferating in response to
Ag presented by APC. mdPBMC from 2 of the unvaccinated steers were depleted of either CD4 or CD8 T
cells and then subjected to 2 rounds of stimulation with
APC pulsed with MMP. Preparations of unseparated
mdPBMC, unstimulated and stimulated, were used as
controls. There was limited cell proliferation in cultures
of mdPBMC depleted of CD4 or CD8 T cell following
two rounds of stimulation with APC pulsed with MMP
(data not shown). In contrast, there was robust proliferation of CD4 and CD8 T cells in the unseparated preparations of mdPBMC following two rounds of stimulation
(results similar to those shown in Figure 5C). Following demonstration that both CD4 and CD8 T cells must
be present for generation of a proliferative and CTL
response to MMP, we used the two steers to determine
which cell subset(s) possessed CTL activity. Negative and
positive selection were used to obtain preparations of Agprimed mdPBMC containing CD4 and CD8 T cells, CD4
T cells, CD8 T cells alone or only γδ T cells. Preparations
of unseparated unstimulated and stimulated mdPBMC
were used as controls. The proliferation (not shown) and
killing activity of unseparated preparations mdPBMC
stimulated with APC, pulsed with MMP, were similar to
the results obtained with all 4 steers (compare Figure 6C
with Figure 6B). Killing activity was less but clearly evident in cell preparations containing both CD4 and CD8

T cells and CD8 T cells alone (Figure 6C). Little or very
limited killing activity was evident in cell preparations
containing CD4 T cells. No killing activity was evident in
the cell preparations containing γδ T cells (Figure 6C).
Role of the perforin/ GnzB pathway in intracellular killing
of Map

Extensive studies have shown intracellular killing of
intracellular bacteria and protozoan parasites is mediated by perforin, Gnz B, and granulysin [29, 30]. We
were interested in determining whether perforin and
granzyme B were also involved in the intracellular killing of Map. A mAb reactive with bovine granulysin was
not available. Nonetheless, we verified a mAb to human
perforin (δG9) identified a conserved epitope on bovine
perforin (data not shown) [31]. Screening of other commercially available mAbs for cross reactivity with bovine
perforin revealed B-D48, a mAb that recognizes a different conserved epitope expressed on the native and newly
synthesized forms of perforin, reacted with bovine perforin [32, 33]. This mAb was selected for further analysis
to determine the pattern of expression of newly synthesized perforin in CD4 and CD8 T cells at the end of the
killing assay. In addition, a recent report showed a mAb
to human GrzB, 351927, cross reacted with bovine GrzB
[34]. We verified the mAbs cross-reactivity with bovine
GrzB and then used it in the present study. The primed
CTL were incubated with uninfected and infected
MoMΦ to determine if recognition of infected cells is
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Figure 6 Comparison of the killing activity of CD4, CD8, and γδ T cells. A Representative set of results illustrated with the C
 T values obtained
with unseparated cell populations. The CT values represent the average of duplicate preparations of DNA run at the same time. B A two-way
ANOVA for the effect of mdPBMC stimulation (two levels: control, MMP), reponses grouped by unvaccinated steers (n = 4). The mean and standard
deviation for each stimulation level (control, MMP) of mdPBMC from four unvaccinated steers. The effect of MMP stimulation was significant
(Fstimulation = 130.4208; P = 0.0014). C No statistics were applied since only two of the four unvaccinated steers were used to obtain data on separated
cell subsets.

necessary to stimulate synthesis of new perforin (Figure 7A). Newly synthesized perforin was only detected
in memory CD4 and CD8 T cells stimulated with MMPpulsed MoDC, with the highest level of expression was
in CD8 T cells (Figure 7A). Comparison of expression of
GnzB showed expression was low in activated memory
CD4 T cells and high in half the activated memory CD8
T cells (Figure 7B).
Infected cells do not undergo apoptosis
during intracellular killing of Map

Studies of the events associated with killing target cells
by CTL have shown that introduction of GrzB into the
cytoplasm of tumor cells or target cells infected with
virus activates caspases that initiate apoptosis and cell
death [35, 36]. The role of apoptosis in the intracellular
killing of bacteria, however, has remained unresolved.

Previous studies of intracellular killing of Mtb by
Thoma-Uzynski et al. [37] showed “host cell apoptosis
is neither sufficient nor necessary for C D8+ CTL to kill
intracellular Mtb” [37]. We used a FC assay to determine if apoptosis is associated with intracellular killing of Map. Comparison of the frequency of necrotic
apoptotic cells in preparations of infected MoMΦ incubated alone vs necrotic apoptotic cells in preparations
of uninfected MoMΦ incubated with primed mdPBMC
showed the frequencies were similar and low. The frequency was a little higher in preparations of infected
MoMΦ incubated with primed mdPBMC (Figure 8).
However, the majority of infected MoMΦ, incubated
under the different conditions, were not necrotic or
apoptotic even after 24 h of incubation. Most of the
cells had intact membranes as detected with 7-AAD.
An additional experiment with infected MoMΦ
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Figure 7 Flow cytometric analysis showing expression of newly synthesized perforin, GnzB in CD4, CD8 T cells. A Newly synthesized
perforin was highly expressed in CD8 T cells from unvaccinated steers with low expression in CD4 T cells (right set of graphs). Newly synthesized
perforin was below the limits of detection in primed mdPBMC incubated with uninfected MoMΦ (center set of graphs). B Expression of GnzB in
infected MoMΦ was low in CD4 T cells. GnzB was present in approximately half of the CD8 T cells.

Infected MoMΦ/
control

Infected MoMΦ/
Uninfected MoMΦ/
MMP-stimulated cells MMP-stimulated cells

FSC

3.64

1.95

13.30

PE Annexin V

5.43

6.83

13.97

7-AAD

7-AAD
2.10 2.34
94.27 1.29

4.54 1.73
93.45 0.28

3.02 11.27
82.53 3.18

PE Annexin V
Figure 8 Comparison of apoptosis in uninfected and infected MoMΦ incubated with MMP-stimulated mdPBMC. The frequency of
apoptosis was low in infected MoMΦ incubated with naïve unprimed mdPBMC and in uninfected MoMΦ incubated with MMP-stimulated
mdPBMC. Although a small increase in apoptosis was observed in infected MoMΦ incubated with MMP-stimulated mdPBMC, the majority of cells in
each cell preparation were neither necrotic nor apoptotic.
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incubated for 3 days with primed mdPBMC showed
the majority of infected MoMΦ were still alive after the
intracellular killing event.

Discussion
The studies presented here were focused on analysis of
the immune response to Map using the natural host. The
initial studies leading up to the present studies showed
all animals exposed to Map under experimental conditions at birth, develop an infection that elicits an immune
response that controls but doesn’t eliminate the pathogen [38, 39]. Flow cytometric analysis of the immune
response to Map and soluble Map Ags ex vivo demonstrated an immune response to Map could be detected
3–5 months post exposure that included CD4 and
CD8 T cells [39]. γδ T cells did not exhibit an Ag specific response. Further analysis with a cannulated ileum
model demonstrated that Map introduced directly into
the ileum are rapidly taken up and disseminated to other
sites without establishing detectable lesions in the ileum
containing Map, as detected by biopsy. In fact, no lesions
were detectable up to 18 months post exposure [24]. A
follow up study comparing the immune response to
human and bovine isolates of Map showed no difference
in the immune response to Map. The one interesting
comparative observation was that it appeared the CD8
T cell response in experimentally infected calves was
delayed, reaching a maximum at 12 months [40]. Development of a method to use site directed mutagenesis
provided opportunity to look at the immune response to
Map in greater detail and determine if any gene product
was essential for establishing a persistent infection. Three
genes were selected for analysis: relA, demonstrated
to impair survival of Mtb in a mouse model [41]; pknG,
shown to affect survival of BCG in macrophages [42];
and lsr2, shown to be involved in mediating multi-drug
resistance to antibiotics [43]. In vivo studies revealed,
similar to the studies in mice with Mtb, that deletion of
relA impaired survival [9, 10]. Comparison of survival
with Map at necropsy showed wild type Map was readily
detected in multiple tissues whereas ΔMap/relA was not
detected in any tissue using culture and PCR. These findings and the ex vivo studies indicated there was a clear
difference in the immune response to the ΔMap/relA
mutant and suggested that deletion of the gene allowed
for the development of an effector T cell response that
cleared the infection. To investigate the immunological
mechanisms accounting for clearance of the mutant, two
steers were vaccinated with ΔMap/relA and maintained
as a source of cells to characterize the effector T cells
ex vivo. We hypothesized the difference in the immune
response to Map and ΔMap/relA might involve signaling mediated through antigen presenting cells (APC).
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To examine this possibility we developed and used a
mAb to CD209 (uniquely expressed on bDC, MoDC,
and MoMΦ) to phenotypically identify and compare
the capacity of bDC, MoDC, and MoMΦ to process and
present Ags to effector memory T cells, elicited by vaccination with ΔMap/relA [12]. The studies revealed the
complexity of the immune response to the mutant. The
study revealed bDC, MoDC, and MoMΦ were essentially
equal in their capacity to process and present Ag to naïve
T cells. Of special interest, all three APCs presented antigenic peptides in context of MHC I and II molecules
simultaneously and provided signaling that elicited a
CD4 and CD8 proliferative response.
Ancillary studies conducted to determine which Map
proteins might be involved in the immune response to
Map, included examining the proliferative response
to the whole and truncated forms of the 35 kDa membrane protein, MMP [13, 44]. A proliferative response
was obtained with the whole and truncated forms of the
protein (unpublished). As reported here, further studies
conducted to determine if MMP was a component of the
recall response, elicited with ΔMap/relA, demonstrated it
was included as a component of the immune response.
Comparative studies demonstrated equivalent recall
responses were obtained with ΔMap/relA and MMP
with all three APCs [12]. The recall response was MHC
restricted [12].
In the present study, we initially used the vaccinated
and control unvaccinated steers to examine the functional activity of memory T cells proliferating in response
to Ag presentation by MoDC pulsed with ΔMap/relA
and MMP. To conduct these studies, a viability assay
was developed based on studies by Worku and Hoft,
using patients with tuberculosis and control subjects
vaccinated with the BCG [25]. In addition, we adapted
an expedient method for distinguishing live from dead
bacteria to obviate the problem of using CFU as a read
out of bacterial viability [17]. Although the conditions
for blocking all gene sites was not optimal for PMA, it
was sufficient to be able to detect differences in live vs
dead bacteria. The scale showed where the residual DNA
from dead cells falls on the curve. The wide dynamic
range between live and dead cells was consistent for
distinguishing between DNA from live and dead bacteria. Comparison of the recall and functional activity of
memory CD4 and CD8 T cells proliferating in response
to Ag presentation by MoDC pulsed with ΔMap/relA
and MMP revealed equivalent CTL activity was elicited
with ΔMap/relA and MMP. The results proved highly
reproducible using APC pulsed with either ΔMap/relA
or MMP. A singular observation made throughout the
studies was, regardless of the route of exposure to Map,
ΔMap/reA, or MMP, exposure resulted in development
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of a CD4 CD8 T cell response [9, 12, 39, 40]. This raised
two questions. Is cognate recognition of Ags by CD4 and
CD8 a requirement for development of CTL activity?
And, do both CD4 and CD8 T cells develop CTL activity?
Only one of these questions could be answered with further studies using vaccinated animals. This prompted us
to explore the possibility of developing an assay to study
the full CTL response ex vivo. The results showed equivalent Ag presentation could be achieved with bDC and
MoDC pulsed with either ΔMap/reA, or MMP. This suggested APC could be used to develop a method to study
the full immune response to Ags ex vivo. If successful, it
would be possible to study mechanisms of Ag processing
and presentation by APC to a relevant pathogen. It would
also make it possible to study the importance of cognate
recognition of antigenic peptides presented in context
of MHC class I and II molecules in development of CTL
activity.
As reported here, four unvaccinated steers were used
to modify the protocol for studying the recall response
starting with stimulation of naïve T cells with bDC
pulsed with ΔMap/relA or MMP followed by a second
round of stimulation with MoDC pulsed with ΔMap/relA
or MMP. After demonstrating equivalent responses
occurred with ΔMap/relA and MMP, further studies were focused on analysis of the immune response
to MMP. The first question of interest was whether the
CD4 and CD8 T cells needed to be present in a culture
to generate CTL. The studies conducted to this point in
the investigation involved use of mdPBMC. Little or no
response was observed if CD4 and CD8 T cells were separated from preparations of mdPBMC before primary Ag
presentation by bDC followed by secondary stimulation
with MoDC. In contrast, a full CTL response was consistently obtained if unseparated mdPBMC were used.
The second question of interest was which T cell subset
possessed the CTL activity. The unproven supposition
was that CTL activity was primarily attributable to CD8
T cells. To answer this question, mdPBMC primed with
APC pulsed with MMP, were separated into 4 populations before incubating with infected MoMΦ target cells.
Cell preparations containing CD4, CD8, and CD4/CD8
were obtained by negative selection. The cell preparation
containing CD8+ and C
 D8− γδ T cells was obtained by
positive selection. Comparison of CTL activity showed
unseparated mdPBMC contained the highest level of
CTL activity followed by the cell preparations containing both CD4 and CD8 T cells and CD8 T cells. Minimal
or no activity was observed with separated CD4 T cells
or γδ T cells. NK cells were not evaluated for potential
CTL activity in this study. Repeat studies showed they
only comprised ~5% of cells present in mdPBMC stimulated with Ag-pulsed bDC and MoDC. The results
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demonstrated the importance of the interaction of CD4
and CD8 T cells in the generation of CTL. Further studies
are needed to detail the signaling associated with interaction of CD4 and CD8 T cells during Ag presentation.
Extensive studies conducted to elucidate the mechanisms used by CTL to kill intracellular bacteria and
protozoan parasites have shown perforin, GrzB, and
granulysin play a role in killing [30, 45]. Our studies
clearly show perforin and GrzB are involved in killing
of Map. Further studies should show granulysin is also
involved. An immune synapse develops on contact of
CTL with the infected cells. Cytotoxic granules migrate
to the synapse allowing perforin molecules to intercalate into the membrane of the target cell and form pores
through which granzymes and granulysin are introduced
into the cytoplasm. Granulysin disrupts the integrity of
the bacterial cell membrane allowing entrance of GrzB
and death of the bacteria [30]. Analysis of effector cells
after incubation with uninfected and infected MoMΦ
showed CTL contact with infected MoMΦ is essential for
killing. Newly synthesized perforin was present in CD8
CTL incubated with infected MoMΦ. Only a few CD4 T
cells contained newly synthesized perforin. In contrast,
there was minimal or no increase in newly synthesized
perforin in primed CD8 CTL incubated with uninfected
MoMΦ. GrzB was detectable in half of the CD8 CTL
with no detectable level in CD4 T cells. These results
indicate the intracellular killing of Map is associated with
upregulation of both perforin and GrzB, mainly in CD8
CTL.
It has remained unclear as to whether apoptosis of the
target cells, mediated by the perforin–granzyme pathway,
is an essential component of the mechanisms of intracellular killing of bacteria. Studies by Thoma-Uszynski et al.
[37] have suggested killing of Mtb is independent of apoptotic death of infected target cells. We conducted studies
to examine this issue. Analysis of apoptosis showed the
majority of infected MoMΦ were still viable after incubation with primed mdPBMC. The average percentages of
apoptotic cells observed in infected MoMΦ co-cultured
with Ag-primed mdPBMC was 13% compared to ~4% in
infected MoMΦ co-cultured with control mdPBMC and
~2% in uninfected MoMΦ co-cultured with Ag-primed
mdPBMC. This is in contrast to CTL mediated killing of
virus infected and cancer cells where apoptosis is clearly
involved [46]. Introduction of GnzB leads to immediate initiation of apoptosis and death of the target cell.
The majority of target cells infected with Map were still
alive even after 3 days of incubation with Ag-primed
mdPBMC. Further studies are needed to explain this
apparent paradox. The interaction between Map and
macrophages is a complex process affected by the lethal
signals released by the CTL involved in the bacterial
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killing and cell apoptosis. Further studies of the roles of
apoptosis in defense against Map infection are needed
to fully explain the results obtained by Thoma-Uszynski
et al. [37] and the results obtained in the present study.
In summary, we have used the natural host to gain a
better understanding of the immune response to Map
and candidate vaccines. Data obtained thus far have
shown relA plays a central role in the ability of Map to
establish a persistent infection and that deletion of relA
leads to immune elimination of the mutant. Ex vivo
analysis has shown MMP is a component of the immune
response to ΔMap/relA. An equivalent CD8 CTL
response is elicited with APC pulsed with ΔMap/relA or
MMP. Simultaneous presentation of antigenic peptides to
CD4 and CD8 by Ag pulsed bDC and MoDC is essential
for generation of CTL. CTL activity is mediated through
the perforin/granzyme pathway. In contrast to CTL
activity against virus infected cells and cancer cells, intracellular killing of bacteria occurs with limited induction
of apoptosis. The assays developed to conduct the studies ex vivo provide opportunities to study the potential
efficacy of candidate vaccines as well as opportunities to
study Ag presentation by DC and consequent proliferation and differentiation of CD4 and CD8 T cells with different functional activity.
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